News for Cumberland Pharmaceuticals Inc. (CPIX)

Cumberland Pharmaceuticals' (CPIX) study shows Caldolor® reduces post-operative morphine needs by 23.2% in patients aged 60 and above. The study report

PR NewswireNASHVILLE, Tenn. and CAMBRIDGE, England, May 13, 2025 Cumberland leveraging Qureight's deep-learning AI platform for its Phase II FIGHTING FIBRO

Cumberland Pharmaceuticals (CPIX) has entered into a strategic collaboration with Qureight, a Core Imaging Laboratory known for its expertise in deep-learning i

Cumberland Pharmaceuticals (CPIX) partners with Qureight to enhance Phase II clinical trial for idiopathic pulmonary fibrosis (IPF). The trial utilizes

Cumberland Pharmaceuticals, Inc. (NASDAQ:CPIX) Q1 2025 Earnings Conference Call May 6, 2024 4:30 PM ETCompany ParticipantsMolly Aggas - Account Supervisor,...

Release Date: May 06, 2025For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Cumberland Pharma

Refinitiv StreetEvents Event TranscriptE D I T E D V E R S I O NCPIX.OQ - Cumberland Pharmaceuticals IncQ1 2025 Cumberland Pharmaceuticals Inc Earnings CallMa

Cumberland Pharmaceuticals Inc (CPIX) released its 8-K filing on May 6, 2025, reporting a significant 38% increase in net revenues for the first quarter of 2025

PR NewswireNASHVILLE, Tenn., May 6, 2025 NASHVILLE, Tenn., May 6, 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmace

Net Revenue (Q4 2024): $10.4 million, an 11.6% increase over the prior year period.Net Revenue (Full Year 2024): $38 million.Product Revenue (Q4 2024): Kristal

Mar 04, 2025 / 09:30PM GMTOperator Good afternoon, and welcome to the Cumberland Pharmaceuticals fourth quarter 2024 financial report and company update. This c

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q4 2024 Earnings Conference Call March 4, 2025 4:30 PM ETCompany ParticipantsMolly Aggas – Account...

Cumberland Pharmaceuticals Inc (CPIX) released its 8-K filing on March 4, 2025, reporting a notable 11.6% increase in fourth-quarter revenue for 2024. The speci

PR NewswireNASHVILLE, Tenn., March 4, 2025 2024 highlights include expanded product labeling, key FDA designations and new study publicationsRecent develop

PR NewswireMAHWAH, N.J., March 3, 2025 MAHWAH, N.J., March 3, 2025 /PRNewswire/ -- Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the acquisition

Glenmark Pharmaceuticals acquires Acetylcysteine Injection for acetaminophen overdose treatment, expanding its US injectable portfolio.

PR NewswireNASHVILLE, Tenn., Feb. 25, 2025 NASHVILLE, Tenn., Feb. 25, 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty phar

PR NewswireNASHVILLE, Tenn. and SHANGHAI, Feb. 18, 2025 Vibativ® is a life-saving antibiotic for pneumonia and serious skin infectionsApproval in China pa

U.S. stocks traded mixed toward the end of trading, with the S&P 500 falling by around 0.1% on Tuesday. The Dow traded down 0.02% to 44,393.25 while the NASDAQ...